Related Experiment Video
Updated: Jan 13, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Platelet aging and desialylation increase apoptotic priming and BCL-XL dependence
Renata Grozovsky1, Cameron S Fraser2,3,4, Xingping Qin2,3,4
1Miller School of Medicine, University of Miami, Miami, FL, USA.
Platelet aging involves losing sialic acid and increasing apoptosis susceptibility, linked to higher BCL-XL dependence. Stimulating new platelet production may prevent thrombocytopenia from BCL-XL inhibitor cancer therapies.
Area of Science:
- Hematology
- Cell Biology
- Cancer Biology
Background:
- Platelets are crucial for hemostasis, immunity, and cancer progression.
- Platelet lifespan is regulated by desialylation and apoptosis, with BCL-XL essential for survival.
- BCL-XL inhibitors show cancer treatment promise but cause thrombocytopenia due to on-target effects.
Purpose of the Study:
- To investigate the relationship between platelet desialylation and apoptosis.
- To understand how this cross-talk impacts platelet lifespan.
- To explore therapeutic strategies for BCL-XL inhibitor-induced thrombocytopenia.
Main Methods:
- Analysis of platelet sialic acid levels and apoptosis markers in circulation and vitro.
- Assessment of BCL-XL dependence in young versus aged platelets.
- In vivo studies using romiplostim to modulate platelet production and prevent thrombocytopenia.
Main Results:
- Platelets progressively desialylate and become more apoptosis-primed with age.
- Desialylation increases BCL-XL dependence and accelerates apoptosis, reversible by sialidase inhibitors.
- Young platelets are less apoptosis-primed and BCL-XL-dependent.
- Romipostim prevents BCL-XL inhibitor-induced thrombocytopenia in vivo.
Conclusions:
- Platelet aging involves a functional link between desialylation and apoptosis, increasing BCL-XL dependence.
- Targeting platelet production with thrombopoietin receptor agonists may mitigate thrombocytopenia associated with BCL-XL inhibitors.
- This offers a potential strategy to enable BCL-XL inhibitor cancer therapy.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Intracellular Signaling Affects Focal Adhesions
Some...

